Bacuyong, Romeo .
HRN: 21-95-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/09/2022
11/15/2022
IV
4.5g
OD
Intraabdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes